Back to Peptide Library
Mitochondrial-Derived Peptide

Humanin

24-Amino-Acid MDP • HNG / S14G-Humanin Analog Research

Humanin is an endogenous mitochondrial-derived peptide studied for cell protection, brain and heart injury models, metabolic signaling, and aging. Most intervention evidence comes from cells and animals; Humanin and its stronger HNG analog have no established human dosing protocol.

Route
SubQ
Compound type
Mitochondrial peptide
Regulatory status
Not FDA approved
Last reviewed
At a glance

Humanin Quick Reference

Low community range
Members only
Sign in to view dosing details.
Standard community range
Members only
Sign in to view dosing details.
Typical course
Members only
Sign in to view dosing details.
Compound
Humanin / HNG
Analog potency differs
Overview

What Is Humanin?

Humanin is a 24-amino-acid peptide encoded within the mitochondrial 16S ribosomal RNA region. It belongs to a family of mitochondrial-derived peptides that also includes MOTS-c and several small humanin-like peptides.

It was first described in 2001 during work on neuronal survival in Alzheimer’s-related models. Humanin occurs naturally in multiple tissues and in circulation, where it appears to participate in cellular stress signaling. Laboratory work has explored cell-surface receptors, BAX interaction, PI3K-AKT and AMPK signaling, oxidative stress, and insulin action.

HNG, or S14G-Humanin, replaces one amino acid and is more potent in many experimental systems. Reports involving HNG should not be treated as interchangeable with native Humanin. Neither version has completed human intervention trials that establish a treatment dose, indication, or long-term safety profile.

Mechanism

Humanin Mechanism of Action

Mitochondrial origin

A short open reading frame in mitochondrial RNA encodes Humanin, allowing it to act as a stress-response signal.

Cell-survival signaling

Laboratory work shows interaction with pro-apoptotic proteins including BAX, potentially altering programmed cell death.

Receptor pathways

Humanin can signal through a cell-surface receptor complex, with downstream STAT3, AKT, and other survival-related responses.

Clinical translation

Cell and animal protection does not establish that injected Humanin improves cognition, heart function, or lifespan in people.

Research findings

Humanin Benefits

Most findings involve cell systems, animal models, or observational human measurements rather than Humanin treatment trials.

Neuroprotection Models

Humanin and HNG protected neurons in amyloid-beta models and improved several Alzheimer’s-related measures in mice.

Cardioprotection Models

HNG reduced infarct size and improved post-ischemic function in animal research, with AMPK and anti-apoptotic signaling implicated.

Insulin Sensitivity

Central Humanin administration improved hepatic and muscle insulin sensitivity in rats; analogs also affected mouse islets.

Lifespan & Healthspan

Humanin overexpression extended lifespan in worms. HNG improved some health markers but did not extend lifespan in one mouse study.

Muscle Cell Protection

A human skeletal-muscle cell experiment found Humanin analog treatment partly reduced dexamethasone-induced atrophy signals; this was not a human dosing trial.

Inflammation Resolution

Human macrophage research links Humanin production during efferocytosis to resolution of inflammation.

Atherosclerosis Models

An HNG analog reduced plaque burden and oxidative-stress measures in ApoE-deficient mice without directly lowering cholesterol.

Cancer Context

Some models suggest healthy-tissue protection during chemotherapy, while a breast-cancer mouse model found tumor progression and reduced chemotherapy response.

Protocol planning

Humanin Dosing Protocol

Members Access Only

Sign in or create a free account to view this content.

Preparation

Humanin Reconstitution

Reconstitution Example

10mg vial + 2mL bacteriostatic water

Result5mg/mL

Reconstitution steps

1
Prepare

Wash your hands, clean the work surface, and wipe both vial stoppers with alcohol. Allow them to dry.

2
Add diluent slowly

Use a new sterile syringe and needle to direct the selected volume of compatible diluent down the inside wall of the vial.

3
Dissolve gently

Swirl or roll the vial until the contents dissolve; do not shake.

4
Storage

Store refrigerated at 2–8°C (36–46°F) and protected from light when the product instructions support this. Record the reconstitution date in your research journal. At this concentration, 25mcg is only 0.5 U-100 units and difficult to measure accurately.

N=1 reports

Humanin Community Experience

Self-reported anecdotal experiences aggregated from public & private peptide community discussions and anonymous peptideprotocols.app user reports. This information does not carry the same weight as published research.

Positive Reports

  • Some describe smoother energy or better sleep as early subjective changes.
  • Improved exercise recovery is occasionally reported, though accounts are sparse.

Negative & Mixed Reports

  • The small self-experimentation community leaves too little report volume for a reliable pattern.
  • Multi-compound stacks make it difficult to attribute changes to Humanin or HNG alone.
  • Some notice no clear effect.
Stacking & synergy

Humanin Stacking & Synergy

These are mechanistic research pairings. No Humanin combination has a validated human protocol, and anti-apoptotic signaling deserves extra care in cancer-related contexts.

Humanin + MOTS-c

Both are mitochondrial-derived peptides. MOTS-c is discussed for metabolic adaptation; Humanin is more often framed around stress and cell-survival signaling.

Humanin + SS-31

SS-31 targets mitochondrial membrane stability while Humanin influences oxidative stress and apoptosis pathways; direct combination data are absent.

Humanin + NAD+

A metabolic-cofactor approach and cell-stress signaling are distinct, but no established interaction or additive outcome is known.

Humanin + FOXO4-DRI

A highly theoretical pairing across aging and apoptosis pathways. Humanin’s anti-apoptotic activity makes attribution and tumor context especially important.

Safety notes

Humanin Side Effects & Safety

Animal tolerability and endogenous production do not establish safety for repeated Humanin or HNG injection in people. Potency, purity, duration, and tumor context are material unknowns.

Community or Immediate Reports

  • Mild injection-site redness, swelling, or discomfort.
  • Occasional GI discomfort, fatigue, headache, or nonspecific malaise.
  • The user base is too small to infer reliable adverse-event rates.

Research Concerns

  • Anti-apoptotic signaling could protect unwanted or malignant cells in some contexts.
  • Humanin promoted tumor progression and impaired doxorubicin response in a triple-negative breast-cancer mouse study.
  • Long-term organ, reproductive, metabolic, immune, and cancer risks in people are unknown.

Humanin Precautions

Avoid or Discuss With a Clinician If
  • Active or prior cancer, especially without oncology guidance.
  • Current chemotherapy, because interactions remain unresolved and animal findings conflict.
  • Known hypersensitivity to Humanin, HNG, or a formulation ingredient.
Use Caution With
  • Pregnancy or breastfeeding; reproductive safety data are absent.
  • Autoimmune conditions or use during childhood and adolescence.
  • Insulin or other glucose-lowering medication, because metabolic effects remain uncertain.
Humanin and HNG are not FDA approved for any indication. No completed human intervention trial has established efficacy, dosing, or long-term safety.
Final verdict

Peptide Protocols Verdict on Humanin

Not medical advice. This editorial is our own opinion piece based off the experience of our own lab rats.
Our opinionated opinion

We find Humanin one of the most intriguing mitochondrial peptides because the cell-protection and neuroprotection story spans so many models. In longevity circles it is often spoken of as a quiet support compound, and some community reports describe smoother energy, sleep, or recovery when stacked with MOTS-c or SS-31.

Our enthusiasm is tempered by how little direct human use data we have. The community is small, Humanin and HNG are often mixed together in reports, and cancer-model findings point in conflicting directions. We would treat it as a niche research compound with an interesting mechanism, not a proven long-term brain-health or longevity tool. That balance earns it a C.